.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Healthtrust
Dow
AstraZeneca
Fish and Richardson
Fuji
US Department of Justice
Citi
Deloitte

Generated: November 24, 2017

DrugPatentWatch Database Preview

Johnson And Johnson Company Profile

« Back to Dashboard

What is the competitive landscape for JOHNSON AND JOHNSON, and when can generic versions of JOHNSON AND JOHNSON drugs launch?

JOHNSON AND JOHNSON has ten approved drugs.

There is one US patent protecting JOHNSON AND JOHNSON drugs.

There are sixteen patent family members on JOHNSON AND JOHNSON drugs in eleven countries.

Summary for Johnson And Johnson

International Patents:16
US Patents:1
Tradenames:12
Ingredients:8
NDAs:10
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Johnson And Johnson
NIZORAL A-D
ketoconazole
SHAMPOO;TOPICAL020310-001Oct 10, 1997OTCYesYes► Subscribe► Subscribe► Subscribe
Johnson And Johnson
WOMEN'S ROGAINE
minoxidil
AEROSOL, FOAM;TOPICAL021812-002Feb 28, 2014OTCYesYes► Subscribe► Subscribe► Subscribe
Johnson And Johnson
MECLAN
meclocycline sulfosalicylate
CREAM;TOPICAL050518-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Johnson And Johnson
GRIFULVIN V
griseofulvin, microcrystalline
SUSPENSION;ORAL050448-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Johnson And Johnson
VASCOR
bepridil hydrochloride
TABLET;ORAL019002-001Dec 28, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe
Johnson And Johnson
VASCOR
bepridil hydrochloride
TABLET;ORAL019002-003Dec 28, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe
Johnson And Johnson
ROGAINE EXTRA STRENGTH (FOR MEN)
minoxidil
SOLUTION;TOPICAL020834-001Nov 14, 1997OTCYesYes► Subscribe► Subscribe► Subscribe
Johnson And Johnson
WOMEN'S ROGAINE
minoxidil
AEROSOL, FOAM;TOPICAL021812-002Feb 28, 2014OTCYesYes► Subscribe► SubscribeY ► Subscribe
Johnson And Johnson
VISINE L.R.
oxymetazoline hydrochloride
SOLUTION/DROPS;OPHTHALMIC019407-001Mar 31, 1989OTCYesYes► Subscribe► Subscribe► Subscribe
Johnson And Johnson
ROGAINE (FOR WOMEN)
minoxidil
SOLUTION;TOPICAL019501-003Feb 9, 1996OTCYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Johnson And Johnson

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Johnson And Johnson
VASCOR
bepridil hydrochloride
TABLET;ORAL019002-001Dec 28, 1990► Subscribe► Subscribe
Johnson And Johnson
NIZORAL A-D
ketoconazole
SHAMPOO;TOPICAL020310-001Oct 10, 1997► Subscribe► Subscribe
Johnson And Johnson
NIZORAL A-D
ketoconazole
SHAMPOO;TOPICAL020310-001Oct 10, 1997► Subscribe► Subscribe
Johnson And Johnson
NIZORAL A-D
ketoconazole
SHAMPOO;TOPICAL020310-001Oct 10, 1997► Subscribe► Subscribe
Johnson And Johnson
VASCOR
bepridil hydrochloride
TABLET;ORAL019002-003Dec 28, 1990► Subscribe► Subscribe
Johnson And Johnson
VASCOR
bepridil hydrochloride
TABLET;ORAL019002-002Dec 28, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Johnson And Johnson Drugs

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)9953923► Subscribe
Canada2328950► Subscribe
Japan2002512192► Subscribe
Australia3323299► Subscribe
Japan2007137899► Subscribe
Austria331517► Subscribe
European Patent Office1695708► Subscribe
Brazil9909796► Subscribe
Germany69932158► Subscribe
European Patent Office1073439► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
QuintilesIMS
Argus Health
Covington
Chubb
Moodys
UBS
Express Scripts
Julphar
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot